Regulation And Legal
NPPA Revises MRP for 543 Anti-Cancer Drug Brands
NPPA released revised Maximum Retail Prices for 543 brands of anti-cancer medicines, effective from November 9, 2026.
Price reductions are substantial, with examples showing 89% reduction for Anastroz
